Novo Nordisk Management
Management criteria checks 0/4
Novo Nordisk's CEO is Maziar Doustdar, appointed in Aug 2025, has a tenure of less than a year. directly owns 0.002% of the company’s shares, worth $3.22M. The average tenure of the management team and the board of directors is 1 years and 0.4 years respectively.
Key information
Maziar Doustdar
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.002% |
| Management average tenure | 1yr |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Maziar Doustdar (55 yo)
Mr. Maziar Mike Doustdar, B.A. (Int. Bus., emphasis in Marketing), serves as an Independent Director of Orion Oyj since March 23, 2022. Mr. Doustdar has been an Executive Vice President at Novo Nordisk A/S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive VP | 8.2yrs | DKK 26.80m | 0.0048% $ 8.0m | |
| President | less than a year | no data | 0.0019% $ 3.2m | |
| EVP of R&D | 5.3yrs | DKK 20.90m | no data | |
| EVP of People | 3.1yrs | no data | no data | |
| Executive VP of Enterprise IT & Quality and Member of Management Board | 1yr | no data | no data | |
| SVP, Group General Counsel | 2yrs | no data | no data | |
| EVP of International Operations & Member of Management Board | less than a year | no data | no data | |
| SVP, Chief of Staff to CEO | no data | no data | no data | |
| Executive VP of US Operations & Member of Management Board | less than a year | no data | no data | |
| Executive VP of Product & Portfolio Strategy and Member of Management Board | less than a year | no data | no data | |
| Senior VP & Head of Investor Relations | no data | no data | no data | |
| Senior Vice President of Medical Affairs | no data | no data | no data |
Experienced Management: NONO.F's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | less than a year | no data | no data | |
| Chair of Board | less than a year | DKK 26.80m | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Vice Chair of the Board | less than a year | no data | no data | |
| Non-Independent Director | 9.1yrs | DKK 1.50m | 0.000010% $ 16.8k | |
| Employee Representative Director | less than a year | no data | no data | |
| Employee Non-Independent Representative Director | 8.1yrs | DKK 1.30m | 0.000070% $ 117.3k | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Employee Representative Director | 4.1yrs | DKK 1.10m | 0.000060% $ 100.6k | |
| Director | less than a year | no data | no data | |
| Employee Representative Director | less than a year | no data | no data |
Experienced Board: NONO.F's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/10 12:00 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novo Nordisk A/S is covered by 55 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Gerhard Schwarz | Baader Helvea Equity Research |
| José Romero Herrero | Banco Santander |